首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >A 'no-wash' albumin-dextran dilution strategy for cord blood unit thaw: high rate of engraftment and a low incidence of serious infusion reactions.
【24h】

A 'no-wash' albumin-dextran dilution strategy for cord blood unit thaw: high rate of engraftment and a low incidence of serious infusion reactions.

机译:用于脐带血单位解冻的“免洗”白蛋白-葡聚糖稀释策略:植入率高,严重的输注反应发生率低。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Preparation of cord blood (CB) units for infusion by albumin-dextran dilution without centrifugation may be advantageous for adult patients to minimize cell loss and, unlike a bedside thaw, is still conducted in the controlled laboratory environment. Therefore, we studied CB transplantation (CBT) using this technique in 54 consecutive CBT recipients >20 kg. Patients (median age=42 years [range: 7-66 years]; median weight=71 kg [range: 24-109]) were transplanted for high-risk hematologic malignancies with myeloablative (n=35) or nonmyeloablative (n=19) conditioning and 4-6/6 human leukocyte antigen (HLA)-matched double-unit grafts. One hundred seven units were thawed with dilution, whereas 1 red blood cell (RBC)-replete unit was washed. A 5:1 dextran 40%/25% albumin solution was used. RBC-depleted units (n=104) were diluted >or=5.5-fold (median final volume 200 mL [range: 200-500]), whereas RBC-replete units (n=3) were diluted >or=4-fold (median final volume 400 mL [range: 400-535]). Total nucleated cell (TNC) recovery was 86%; the median infused TNC dose was 2.17x10(7)/kg/unit. Although 35 patients (65%) had a total of 45 infusion reactions (6 nausea, 31 hypertension, 3 pain, 1 rigors/fever, 2 transient hypoxia, 2 renal impairment) requiring additional therapy, there were no infusion-related serious adverse events, and reactions were not related to dimethyl sulfoxide (DMSO) dose/kg. Cumulative incidence of sustained donor engraftment was 94% (95% cumulative incidence [CI]: 87-100) with neutrophil recovery occurring at a median of 25 days (range: 13-43) in myeloablative and 10 days (range: 7-36) in nonmyeloablative recipients. CB thaw with albumin-dextran dilution reduces unit manipulation, and minimizes cell loss, speeds time to infusion, is associated with a tolerable infusion reaction profile, and a high rate of sustained engraftment in CBT recipients >or=20 kg.
机译:通过白蛋白-右旋糖酐稀释而无需离心制备用于输注的脐带血(CB)单元可能对成年患者有利,以最大程度地减少细胞损失,并且与床旁融化不同,仍在受控实验室环境中进行。因此,我们在54名连续的CBT接受者> 20 kg中研究了使用这种技术的CB移植(CBT)。患者(中位年龄= 42岁[范围:7-66岁];中位体重= 71 kg [范围:24-109])被移植为高风险血液恶性肿瘤,伴清髓性(n = 35)或非清髓性(n = 19) )条件处理和4-6 / 6人白细胞抗原(HLA)匹配的双单位移植物。稀释后解冻了一百七个单位,而洗涤了一个充满红细胞(RBC)的单位。使用5:1的葡聚糖40%/ 25%白蛋白溶液。贫RBC单位(n = 104)稀释>或= 5.5倍(中位数最终体积200 mL [范围:200-500]),而富RBC单位(n = 3)稀释>或= 4倍(中位数最终体积为400毫升[范围:400-535])。总有核细胞(TNC)回收率为86%; TNC的中位剂量为2.17x10(7)/ kg /单位。尽管35例患者(65%)总共需要进行其他输注反应45次(6例恶心,31例高血压,3例疼痛,1次严峻/发烧,2例短暂性低氧,2例肾功能不全),但没有发生与输注相关的严重不良事件,反应与二甲基亚砜(DMSO)剂量/ kg无关。持续供体植入的累积发生率为94%(95%累积发生率[CI]:87-100),清髓性和中性白细胞恢复发生时间分别为25天(范围:13-43)和10天(范围:7-36) )在非清髓性接受者中。用白蛋白-葡聚糖稀释的CB解冻减少了单位操作,使细胞损失最小化,加快了输注时间,与可耐受的输注反应谱以及CBT接受者≥20 kg的高持续植入率有关。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号